Clinical Trials
3 trialsNCT07224776 2026-05-18
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Brigham and Women's Hospital
Phase 1 Not yet recruiting
NCT07358520 2026-01-22
Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients
Fudan University
Phase 4 Not yet recruiting
NCT07355361 2026-01-21
N093
Fudan University
Phase 2 Not yet recruiting